Partner insight: Which is better for multi-asset - active or passive?

Passive funds have outperformed over the past 10 years but may not do so forever, says Henk-Jan Rikkerink

clock • 1 min read
Partner insight: Which is better for multi-asset - active or passive?

With inflation at high levels, advisers are paying closer attention to costs than ever before. As a result, passive funds have continued to appeal.

The cost advantages of passive funds are well known, and last year, Fidelity was able to reduce the ongoing charges figure (OCF) across its passive Multi Asset Allocator fund range from 0.25% to 0.2%.

Performance has played a part in passive's appeal too, of course. "We've been in a world where passive funds have beaten lots of active funds," says Rikkerink. "We may not be in that world forever, but we have been for the last 10 years in large parts of the market."

That said, many investors continue to prefer active products, and Rikkerink puts this down to risk-return calculations. "Certainly, we're of the belief that even though the sticker price might be a little bit higher, the extra return you get from adding in private markets can make sense in some portfolios," he says.

"But by no means will all clients be willing to go down that route," he adds. "There will be a range of different demands out there and it won't be in every product."

 

 

More on Economics / Markets

In-depth

Advisers warned against 'cost-saving' exercises as FCA proposes ditching annual suitability requirement

Advisers warned against 'cost-saving' exercises as FCA proposes ditching annual suitability requirement

Changes offer an opportunity for more ‘meaningful’ advice

Sophia Panayi
clock 26 March 2026 • 4 min read
Advisers on Iran war: 'My advice goes well beyond just saying don't panic'

Advisers on Iran war: 'My advice goes well beyond just saying don't panic'

‘Clients are naturally concerned’

clock 11 March 2026 • 5 min read
What does the Schroders/Nuveen deal mean for Benchmark advisers?

What does the Schroders/Nuveen deal mean for Benchmark advisers?

ARs await deal impact amid future sale suggestions

Isabel Baxter
clock 26 February 2026 • 5 min read